I
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K322.2 KBInozyme Pharma, Inc.Jul 1, 9:25 AM ET·0001193125-25-153582
- 8-K157.8 KBInozyme Pharma, Inc.Jun 20, 7:29 PM ET·0001193125-25-143825
- 8-K141.4 KBInozyme Pharma, Inc.Jun 2, 7:35 AM ET·0001193125-25-132782
- 8-K943.2 KBInozyme Pharma, Inc.May 16, 8:06 AM ET·0001193125-25-121310
- 10-Q9.2 MBInozyme Pharma, Inc.May 14, 7:36 AM ET·0000950170-25-070921
- 8-K509.4 KBInozyme Pharma, Inc.May 14, 7:33 AM ET·0000950170-25-070917
- 10-K26.3 MBInozyme Pharma, Inc.Mar 10, 8:32 AM ET·0000950170-25-035940
- 8-K301.2 KBInozyme Pharma, Inc.Mar 10, 8:31 AM ET·0000950170-25-035939
- 8-K10.3 MBInozyme Pharma, Inc.Jan 10, 8:06 AM ET·0001193125-25-004124
- SC 13G44.6 KBInozyme Pharma, Inc.Dec 9, 4:14 PM ET·0001839882-24-044356
Insiders
10Tickers
No tickers on record
Addresses
business
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
mailing
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
Former Names
- Inozyme Pharma, LLC2017-01-05